GLAUKOS Corp (GKOS) research
GLAUKOS Corp- Sector
- Health Care
- Last price
- $163.75
- As of
GLAUKOS Corp (GKOS): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-03.
As of . Source: SEC EDGAR filings for GKOS. Method and limitations.
Share the GKOS intelligence card
See the full GKOS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GKOS on one page. Preview it with sample data, then open it live with a free account.
Preview the GKOS dossierActive signals for GKOS
- highCONSENSUS_BUY
4 tracked funds increased GKOS this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 99% of GKOS (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 98% of GKOS (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +4398% to GKOS (2026Q2)
- highINSTITUTIONAL_EXIT
D. E. Shaw & Co., Inc. cut 77% of GKOS (2026Q2)
FREE, NO ACCOUNT
Every signal on GKOS, as it fires
You are seeing 5 of 14 signals recorded on GKOS since 2026-05-29.
The five above landed across 2 days. The other 9 were recorded on 3 other days. 8 of the 14 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in GKOS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 377322102 · 2026Q2 | $221M | 0.08% | , |
| CITADEL ADVISORS LLCCUSIP 377322102 · 2026Q2 | $194.3M | 0.02% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 377322102 · 2026Q2 | $20.6M | 0.03% | , |
| Point72 Asset Management, L.P.CUSIP 377322102 · 2026Q2 | $19.3M | 0.02% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 377322102 · 2026Q2 | $8.9M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 377322102 · 2026Q2 | $8M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 377322102 · 2026Q2 | $463K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, GKOS
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
GKOS against its peers
GKOS's operating margin of -39.3% ranks in the 10th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | GKOS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 507M USD | 1.9B USD | 2 | 25 |
| Gross margin | 55.7% | 60.1% | 38 | 16 |
| Operating margin | -39.3% | 8.5% | 10 | 23 |
| Net margin | -37.0% | 5.5% | 13 | 25 |
| Return on equity | -28.6% | 11.9% | 14 | 24 |
| P / E | n/a | 35.2x | n/a | 18 |
Peers (25): MASI, MOH, ENSG, HNGE, BTSG, EHC, HIMS, PEN, PACS, CHE, LNTH, RDNT, TFX, MMSI, DOCS, WAY, HAE, ITGR, THC, LIVN, NVST, IRTC, CRVL, GH, OPCH. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (GKOS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more GKOS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GKOSand get the insider, 13F, options, and confluence read in one view.